CTSOVSSLXN• 3 Months (Normalized)
CTSO vs SLXN (Cytosorbents Corporation vs Silexion Therapeutics Corp)
Showing Closing Date Range from Jun 30 to Sep 28, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
CTSO Performance $4.91
+1212.83%
Cytosorbents Corporation
Normalized Baseline0.00%
SLXN Performance $0.32
-87.65%
Silexion Therapeutics Corp
Normalized Baseline0.00%
Alpha Spread Margin CTSO LEADS
+1300.48 pts
CTSO outperforming by 1300.48 percentage points
CTSOSLXN
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
CTSO SLXN
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(60 dates)
| Date | CTSO Price | CTSO Gain (%) | SLXN Price | SLXN Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 23, 2026 | $4.91 | +1212.83% | $0.32 | -87.65% | +1300.48% |
| Sep 22, 2026 | $- | $0.39 | -84.63% | - | |
| Sep 21, 2026 | $5.51 | +1373.26% | $0.54 | -78.67% | +1451.93% |
| Sep 18, 2026 | $5.75 | +1437.43% | $0.44 | -82.90% | +1520.33% |
| Sep 17, 2026 | $5.76 | +1440.11% | $0.38 | -85.10% | +1525.21% |
| Sep 16, 2026 | $5.73 | +1432.09% | $0.34 | -86.67% | +1518.76% |
| Sep 15, 2026 | $6.06 | +1520.32% | $0.34 | -86.67% | +1606.99% |
| Sep 14, 2026 | $6.07 | +1522.99% | $0.39 | -84.89% | +1607.88% |
| Sep 11, 2026 | $6.41 | +1613.90% | $0.36 | -86.00% | +1699.90% |
| Sep 10, 2026 | $6.37 | +1603.21% | $0.42 | -83.41% | +1686.62% |
| Sep 09, 2026 | $6.33 | +1592.51% | $0.35 | -86.27% | +1678.78% |
| Sep 08, 2026 | $- | $0.35 | -86.47% | - | |
| Sep 04, 2026 | $0.35 | -6.42% | $0.35 | -86.20% | +79.78% |
| Sep 03, 2026 | $0.35 | -6.42% | $0.35 | -86.20% | +79.78% |
| Sep 02, 2026 | $0.38 | +2.67% | $0.35 | -86.24% | +88.91% |
Page 1 of 4